ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
Superinvestors holding IMGN, Q4 2023
1 superinvestor reports holding ImmunoGen, Inc. on Form 13F, worth $73.9M in total. Weight is ImmunoGen, Inc.'s share of each 13F portfolio; actions compare shares with Q3 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | 1.5% | 2,493,217 | $73.9M | Reduced−1.0% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of IMGN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−1.0%)
Q3 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−33.5%)
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−51.8%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+14.2%)
Q4 2022
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+93.6%)
Q3 2022
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+28.4%)
Q2 2022
1 superinvestor holding at quarter end